Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced the launch of its Protein G Total Antibody Quantification Kit. The new kit is ...
CAMBRIDGE, England--(BUSINESS WIRE)--Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia™ assay portfolio with the ...
Abselion has launched the His-Tagged Protein Quantification Kit for use with its Amperia™ benchtop platform. Developed with GenScript’s THE™ His Tag Monoclonal Antibodies, the kit enables rapid ...
One of the hardest things to do when you establish an experiment that requires the measurement of proteins, cytokines, or biomarkers is the selection of the appropriate assay kit. Product catalogs are ...
Abselion has introduced the AAVX Total Capsid Quantification Kit and the AAV9 Total Capsid Quantification Kit for use with its Amperia™ benchtop quantification platform. Both kits incorporate Thermo ...
The last two weeks have been packed with collaborations for unveiling innovative products and kick-starting prosperous partnerships. From quantifying His-tagged proteins and characterizing mutations ...
Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes Kits incorporate Thermo Fisher Scientific’s CaptureSelect affinity reagents for ...
Abselion Launches His-tagged Protein Quantification Kit and Sensors for Amperia at PEGS Europe 2025 Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable ...
The AAV9 Total Capsid Quantification Kit incorporates CaptureSelect Anti-AAV9 Biotin and HRP Conjugates for focused quantification of AAV9 particles. Dr Ruizhi Wang, CEO and Founder, Abselion, said: ...
Abselion, has expanded its Amperia™ assay portfolio with the launch of its Tagged Protein Quantification Kit | His-tag and Tagged Protein Sensor | His-tag Quantification. The novel assay, developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results